Ruth Shaber, Md

Women of the World Endowment ("WoWE") is the first 100% mission-aligned endowment investing our capital in and through women for market-rate risk adjusted returns and deep impact. We build pathways to mainstream investing in and through women as the Changemakers who drive resilient and sustainable investment systems, communities and economies. We invite co-investing to expand the capital pool. Our returns are granted to organizations accelerating the opportunity of women addressing today’s most pressing challenges through systems transformation. We are creating a virtuous circle of capital that spans the entire investment spectrum and maximizes outcomes for all. WoWE’s public markets portfolio has been outperforming its benchmark including through the COVID-19 context highlighting that a gender lens investing (GLI) strategy can deliver robust results.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.

Born in Portugal, Futura is a diverse community of future thinkers, dreamers & doers supporting talented women to shape a newly imagined world.

Toniic is a global community of private asset owners seeking to steward wealth and use influence to enable a thriving world. Our members – more than 500 high net-wealth individuals, family offices, and foundations from more than 25 countries – are active impact investors and philanthropists, for whom Toniic provides a vibrant community, with education, investment opportunities, impact support, and events. Toniic also builds the field of impact investing, leading by example to move money and mindsets. For a view into our world please visit: www.toniic.com

Women of the World Endowment ("WoWE") is the first 100% mission-aligned endowment investing our capital in and through women for market-rate risk adjusted returns and deep impact. We build pathways to mainstream investing in and through women as the Changemakers who drive resilient and sustainable investment systems, communities and economies. We invite co-investing to expand the capital pool. Our returns are granted to organizations accelerating the opportunity of women addressing today’s most pressing challenges through systems transformation. We are creating a virtuous circle of capital that spans the entire investment spectrum and maximizes outcomes for all. WoWE’s public markets portfolio has been outperforming its benchmark including through the COVID-19 context highlighting that a gender lens investing (GLI) strategy can deliver robust results.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.